Amphastar Pharmaceuticals (AMPH) PT Lowered to $21 at Piper Sandler
Tweet
Share
E-mailGet Alerts AMPH Hot Sheet
Price: $21.78 +3.52%
Rating Summary:
2 Buy, 9 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 20 | New: 25
Rating Summary:
2 Buy, 9 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 20 | New: 25
Join SI Premium – FREE
Piper Sandler analyst David Amsellem lowered the price target on Amphastar Pharmaceuticals (NASDAQ: AMPH) to $21.00 (from $25.00) while maintaining a Neutral rating.
You May Also Be Interested In
- LTIMindtree Ltd (LTIM:IN) PT Lowered to INR3,455 at Citi
- One 97 Communications Ltd (PAYTM:IN) PT Raised to INR1,430 at Goldman Sachs
- SSR Mining (SSRM:CN) (SSRM) PT Raised to Cdn$58 at Scotiabank
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
